Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Axon guidance 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬Axon guidance
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 2 | Axon guidance 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬Axon guidance
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 3 | Axon guidance 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Axon guidance
| Dasatinib | 013 [3] 13, 51, 85 💬3. Axon guidance
|
||||||||||||||||||||||||||||||||||
| 4 | Axon guidance 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Axon guidance
| Dasatinib | 013 [3] 13, 51, 85 💬3. Axon guidance
|
||||||||||||||||||||||||||||||||||
| 5 | Axon guidance 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Axon guidance
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬5. Axon guidance
|
||||||||||||||||||||||||||||||||||
| 6 | Axon guidance 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Axon guidance
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬5. Axon guidance
|
||||||||||||||||||||||||||||||||||
| 7 | Axon guidance 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬Axon guidance
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬7. Axon guidance
|
||||||||||||||||||||||||||||||||||
| 8 | Axon guidance 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬Axon guidance
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 9 | Cell cycle 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬Cell cycle
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 10 | Cell cycle 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬Cell cycle
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 11 | Cell cycle 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Cell cycle
| Dasatinib | 013 [3] 13, 51, 85 💬11. Cell cycle
|
||||||||||||||||||||||||||||||||||
| 12 | Cell cycle 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Cell cycle
| Dasatinib | 013 [3] 13, 51, 85 💬11. Cell cycle
|
||||||||||||||||||||||||||||||||||
| 13 | Cell cycle 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Cell cycle
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬13. Cell cycle
|
||||||||||||||||||||||||||||||||||
| 14 | Cell cycle 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Cell cycle
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬13. Cell cycle
|
||||||||||||||||||||||||||||||||||
| 15 | Cell cycle 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬Cell cycle
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬15. Cell cycle
|
||||||||||||||||||||||||||||||||||
| 16 | Cell cycle 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬Cell cycle
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 17 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬Chemical carcinogenesis - reactive oxygen species
| Bosutinib | 002 [2] 2 , 67 💬17. Chemical carcinogenesis - reactive oxygen species |
||||||||||||||||||||||||||||||||||
| 18 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬Chemical carcinogenesis - reactive oxygen species
| Bosutinib | 002 [2] 2 , 67 💬17. Chemical carcinogenesis - reactive oxygen species |
||||||||||||||||||||||||||||||||||
| 19 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Chemical carcinogenesis - reactive oxygen species
| Dasatinib | 013 [3] 13, 51, 85 💬19. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||
| 20 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Chemical carcinogenesis - reactive oxygen species
| Dasatinib | 013 [3] 13, 51, 85 💬19. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||
| 21 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Chemical carcinogenesis - reactive oxygen species
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬21. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||
| 22 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Chemical carcinogenesis - reactive oxygen species
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬21. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||
| 23 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬Chemical carcinogenesis - reactive oxygen species
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬23. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||
| 24 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬Chemical carcinogenesis - reactive oxygen species
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 25 | Chronic myeloid leukemia 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬Chronic myeloid leukemia
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 26 | Chronic myeloid leukemia 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬Chronic myeloid leukemia
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 27 | Chronic myeloid leukemia 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Chronic myeloid leukemia
| Dasatinib | 013 [3] 13, 51, 85 💬27. Chronic myeloid leukemia
|
||||||||||||||||||||||||||||||||||
| 28 | Chronic myeloid leukemia 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Chronic myeloid leukemia
| Dasatinib | 013 [3] 13, 51, 85 💬27. Chronic myeloid leukemia
|
||||||||||||||||||||||||||||||||||
| 29 | Chronic myeloid leukemia 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Chronic myeloid leukemia
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬29. Chronic myeloid leukemia
|
||||||||||||||||||||||||||||||||||
| 30 | Chronic myeloid leukemia 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Chronic myeloid leukemia
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬29. Chronic myeloid leukemia
|
||||||||||||||||||||||||||||||||||
| 31 | Chronic myeloid leukemia 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬Chronic myeloid leukemia
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬31. Chronic myeloid leukemia
|
||||||||||||||||||||||||||||||||||
| 32 | Chronic myeloid leukemia 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬Chronic myeloid leukemia
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 33 | ErbB signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬ErbB signaling pathway
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 34 | ErbB signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬ErbB signaling pathway
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 35 | ErbB signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬ErbB signaling pathway
| Dasatinib | 013 [3] 13, 51, 85 💬35. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||
| 36 | ErbB signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬ErbB signaling pathway
| Dasatinib | 013 [3] 13, 51, 85 💬35. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||
| 37 | ErbB signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬ErbB signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬37. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||
| 38 | ErbB signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬ErbB signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬37. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||
| 39 | ErbB signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬ErbB signaling pathway
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬39. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||
| 40 | ErbB signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬ErbB signaling pathway
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 41 | IgSF CAM signaling 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬IgSF CAM signaling
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 42 | IgSF CAM signaling 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬IgSF CAM signaling
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 43 | IgSF CAM signaling 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬IgSF CAM signaling
| Dasatinib | 013 [3] 13, 51, 85 💬43. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||
| 44 | IgSF CAM signaling 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬IgSF CAM signaling
| Dasatinib | 013 [3] 13, 51, 85 💬43. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||
| 45 | IgSF CAM signaling 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬IgSF CAM signaling
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬45. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||
| 46 | IgSF CAM signaling 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬IgSF CAM signaling
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬45. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||
| 47 | IgSF CAM signaling 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬IgSF CAM signaling
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬47. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||
| 48 | IgSF CAM signaling 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬IgSF CAM signaling
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 49 | MicroRNAs in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬MicroRNAs in cancer
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 50 | MicroRNAs in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬MicroRNAs in cancer
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 51 | MicroRNAs in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬MicroRNAs in cancer
| Dasatinib | 013 [3] 13, 51, 85 💬51. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||
| 52 | MicroRNAs in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬MicroRNAs in cancer
| Dasatinib | 013 [3] 13, 51, 85 💬51. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||
| 53 | MicroRNAs in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬MicroRNAs in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬53. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||
| 54 | MicroRNAs in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬MicroRNAs in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬53. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||
| 55 | MicroRNAs in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬MicroRNAs in cancer
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬55. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||
| 56 | MicroRNAs in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬MicroRNAs in cancer
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 57 | Neurotrophin signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬Neurotrophin signaling pathway
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 58 | Neurotrophin signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬Neurotrophin signaling pathway
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 59 | Neurotrophin signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Neurotrophin signaling pathway
| Dasatinib | 013 [3] 13, 51, 85 💬59. Neurotrophin signaling pathway
|
||||||||||||||||||||||||||||||||||
| 60 | Neurotrophin signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Neurotrophin signaling pathway
| Dasatinib | 013 [3] 13, 51, 85 💬59. Neurotrophin signaling pathway
|
||||||||||||||||||||||||||||||||||
| 61 | Neurotrophin signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Neurotrophin signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬61. Neurotrophin signaling pathway
|
||||||||||||||||||||||||||||||||||
| 62 | Neurotrophin signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Neurotrophin signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬61. Neurotrophin signaling pathway
|
||||||||||||||||||||||||||||||||||
| 63 | Neurotrophin signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬Neurotrophin signaling pathway
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬63. Neurotrophin signaling pathway
|
||||||||||||||||||||||||||||||||||
| 64 | Neurotrophin signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬Neurotrophin signaling pathway
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 65 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬Pathogenic Escherichia coli infection
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 66 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬Pathogenic Escherichia coli infection
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 67 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Pathogenic Escherichia coli infection
| Dasatinib | 013 [3] 13, 51, 85 💬67. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||
| 68 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Pathogenic Escherichia coli infection
| Dasatinib | 013 [3] 13, 51, 85 💬67. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||
| 69 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Pathogenic Escherichia coli infection
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬69. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||
| 70 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Pathogenic Escherichia coli infection
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬69. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||
| 71 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬Pathogenic Escherichia coli infection
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬71. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||
| 72 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬Pathogenic Escherichia coli infection
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 73 | Pathways in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬Pathways in cancer
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 74 | Pathways in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬Pathways in cancer
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 75 | Pathways in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Pathways in cancer
| Dasatinib | 013 [3] 13, 51, 85 💬75. Pathways in cancer
|
||||||||||||||||||||||||||||||||||
| 76 | Pathways in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Pathways in cancer
| Dasatinib | 013 [3] 13, 51, 85 💬75. Pathways in cancer
|
||||||||||||||||||||||||||||||||||
| 77 | Pathways in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Pathways in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬77. Pathways in cancer
|
||||||||||||||||||||||||||||||||||
| 78 | Pathways in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Pathways in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬77. Pathways in cancer
|
||||||||||||||||||||||||||||||||||
| 79 | Pathways in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬Pathways in cancer
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬79. Pathways in cancer
|
||||||||||||||||||||||||||||||||||
| 80 | Pathways in cancer 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬Pathways in cancer
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 81 | Ras signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬Ras signaling pathway
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 82 | Ras signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬Ras signaling pathway
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 83 | Ras signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Ras signaling pathway
| Dasatinib | 013 [3] 13, 51, 85 💬83. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||
| 84 | Ras signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Ras signaling pathway
| Dasatinib | 013 [3] 13, 51, 85 💬83. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||
| 85 | Ras signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Ras signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬85. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||
| 86 | Ras signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Ras signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬85. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||
| 87 | Ras signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬Ras signaling pathway
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬87. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||
| 88 | Ras signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬Ras signaling pathway
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||||
| 89 | Viral myocarditis 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib Bosutinib 💬Viral myocarditis
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 90 | Viral myocarditis 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Bosutinib hydrate Bosutinib hydrate 💬Viral myocarditis
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||||
| 91 | Viral myocarditis 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Viral myocarditis
| Dasatinib | 013 [3] 13, 51, 85 💬91. Viral myocarditis
|
||||||||||||||||||||||||||||||||||
| 92 | Viral myocarditis 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Dasatinib Dasatinib 💬Viral myocarditis
| Dasatinib | 013 [3] 13, 51, 85 💬91. Viral myocarditis
|
||||||||||||||||||||||||||||||||||
| 93 | Viral myocarditis 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Viral myocarditis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬93. Viral myocarditis
|
||||||||||||||||||||||||||||||||||
| 94 | Viral myocarditis 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Viral myocarditis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬93. Viral myocarditis
|
||||||||||||||||||||||||||||||||||
| 95 | Viral myocarditis 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Nilotinib Nilotinib 💬Viral myocarditis
| Nilotinib | 006 [5] 6 , 8 , 34, 51, 86 💬95. Viral myocarditis
|
||||||||||||||||||||||||||||||||||
| 96 | Viral myocarditis 💬 1 gene, 5 drugs (DrugBank) and 17 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Saracatinib Saracatinib 💬Viral myocarditis
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
Axon guidance
1 gene, 5 drugs (DrugBank) and 17 diseases
Cell cycle
1 gene, 5 drugs (DrugBank) and 17 diseases
Chemical carcinogenesis - reactive oxygen species
1 gene, 5 drugs (DrugBank) and 17 diseases
Chronic myeloid leukemia
1 gene, 5 drugs (DrugBank) and 17 diseases
ErbB signaling pathway
1 gene, 5 drugs (DrugBank) and 17 diseases
IgSF CAM signaling
1 gene, 5 drugs (DrugBank) and 17 diseases
MicroRNAs in cancer
1 gene, 5 drugs (DrugBank) and 17 diseases
Neurotrophin signaling pathway
1 gene, 5 drugs (DrugBank) and 17 diseases
Pathogenic Escherichia coli infection
1 gene, 5 drugs (DrugBank) and 17 diseases
Pathways in cancer
1 gene, 5 drugs (DrugBank) and 17 diseases
Ras signaling pathway
1 gene, 5 drugs (DrugBank) and 17 diseases
Viral myocarditis
1 gene, 5 drugs (DrugBank) and 17 diseases
